The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis


Creative Commons License

Yildirim M., KAYA V. , Demirpence O., PAYDAŞ S.

ARCHIVES OF MEDICAL SCIENCE, vol.11, no.4, pp.708-714, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 11 Issue: 4
  • Publication Date: 2015
  • Doi Number: 10.5114/aoms.2015.53289
  • Title of Journal : ARCHIVES OF MEDICAL SCIENCE
  • Page Numbers: pp.708-714

Abstract

Introduction: Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). Although gender has not been included in prognostic systems, male gender has been found as a bad prognostic indicator in Hodgkin lymphoma, follicular lymphoma and chronic lymphocytic leukemia. The relationship between gender and prognosis is not clear in patients with DLBCL treated with rituximab-containing regimens. The aim of this meta-analysis is to determine the prognostic/predictive role of gender in patients with DLBCL treated with rituximab-containing regimens.